Advisornet Financial’s Amphastar Pharmaceuticals AMPH Stock Holding History

Advisornet Financial’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3	Closed	-$186	–	2063
2023 Q4	$186	Sell	3 -1	-25%	-$53	﹤0.01%	2310
2023 Q3	$184	Buy	4 +3	+300%	+$164	﹤0.01%	2148
2023 Q2	$57	Hold	1	–	–	﹤0.01%	2305
2023 Q1	$38	Hold	1	–	–	﹤0.01%	2367
2022 Q4	$28	Buy	+1	New	+$29	﹤0.01%	2358
2022 Q2	–	Sell	-3,000	Closed	-$108K	–	1865
2022 Q1	$108K	Hold	3,000	–	–	0.01%	728
2021 Q4	$70K	Hold	3,000	–	–	﹤0.01%	906
2021 Q3	$57K	Hold	3,000	–	–	﹤0.01%	966
2021 Q2	$60K	Buy	+3,000	New	+$56.5K	﹤0.01%	923

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Advisornet Financial's AMPH Position: Q1 2024 in Review

Advisornet Financial sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2024, closing a stake of 3 shares — an estimated $186 sold.

Advisornet Financial first reported a position in AMPH in Q2 2021 and held it in 9 quarters. The position peaked at $108K in Q1 2022. 270 funds tracked by Wall St. Rank hold AMPH as of Q1 2024.

Advisornet Financial reported no remaining Amphastar Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
Advisornet Financial sold 3 Amphastar Pharmaceuticals shares in Q1 2024, an estimated $186.
Advisornet Financial first reported a position in Amphastar Pharmaceuticals in Q2 2021 and held it in 9 quarters.
Advisornet Financial's Amphastar Pharmaceuticals position peaked at $108K in Q1 2022.
270 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2024.

Based on Advisornet Financial's 13F filing for Q1 2024, filed 12 Apr 2024.